InvestSMART

Pro Medicus Limited (ASX: PME) - Announcements

Current share price for PME : $196.750 20.89 (11.88%)+

ASX company news and announcements for Pro Medicus Limited (PME) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Pro Medicus Limited (PME) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Pro Medicus Limited (PME), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Pro Medicus Limited (PME)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$20,554 Notification of cessation of securities - PME 27 Feb 2024 3:46PM $100.830 $196.750 risen by 95.13%
$20,554 Notification of cessation of securities - PME 27 Feb 2024 3:45PM $100.830 $196.750 risen by 95.13%
$20,554 Notification of cessation of securities - PME 27 Feb 2024 3:44PM $100.830 $196.750 risen by 95.13%
$20,554 Update - Notification of buy-back - PME 26 Feb 2024 8:08AM $98.220 $196.750 risen by 100.32%
$20,554 Update - Notification of buy-back - PME 23 Feb 2024 8:07AM $94.530 $196.750 risen by 108.13%
$20,554 Update - Notification of buy-back - PME 22 Feb 2024 8:09AM $92.990 $196.750 risen by 111.58%
$20,554 Change of Director's Interest Notice - Alice Williams 21 Feb 2024 8:15AM $94.830 $196.750 risen by 107.48%
$20,554 Notification of cessation of securities - PME 21 Feb 2024 8:11AM $94.830 $196.750 risen by 107.48%
$20,554 Notification of cessation of securities - PME 21 Feb 2024 8:10AM $94.830 $196.750 risen by 107.48%
$20,554 Update - Notification of buy-back - PME 21 Feb 2024 8:05AM $94.830 $196.750 risen by 107.48%
$20,554 Cancel - Notification of buy-back - PME 20 Feb 2024 10:50AM $89.970 $196.750 risen by 118.68%
$20,554 Update - Notification of buy-back - PME 20 Feb 2024 10:38AM $89.790 $196.750 risen by 119.12%
$20,554 Notification of buy-back - PME 20 Feb 2024 9:52AM $87.560 $196.750 risen by 124.70%
$20,554 Change of Director's Interest Notice - Alice Williams 16 Feb 2024 2:25PM $87.680 $196.750 risen by 124.40%
$20,554 HY24 Results Presentation 15 Feb 2024 11:04AM $102.630 $196.750 risen by 91.71%
$20,554 CEO Interview - 1H24 results 15 Feb 2024 9:25AM $108.090 $196.750 risen by 82.02%
$20,554 Dividend/Distribution - PME 15 Feb 2024 9:22AM $108.090 $196.750 risen by 82.02%
$20,554 Company Announcement - Interim Results 15 Feb 2024 9:16AM $108.090 $196.750 risen by 82.02%
$20,554 Appendix 4D 15 Feb 2024 9:15AM $108.090 $196.750 risen by 82.02%
$20,554 Half Year Accounts 15 Feb 2024 9:15AM $108.090 $196.750 risen by 82.02%
$20,554 PME launches Visage Ease VP for Apple Vision Pro 5 Feb 2024 9:00AM $104.800 $196.750 risen by 87.74%
$20,554 PME HY Results release date and webcast briefing 16 Jan 2024 8:56AM $97.110 $196.750 risen by 102.61%
$20,554 Change of Director's Interest Notice - Alice Williams 27 Nov 2023 12:08PM $88.010 $196.750 risen by 123.55%
$20,554 PME Cleansing Notice - Sam Hupert 21 Nov 2023 12:22PM $88.490 $196.750 risen by 122.34%
$20,554 PME Cleansing Notice - Anthony Hall 21 Nov 2023 12:20PM $88.490 $196.750 risen by 122.34%

176 - 200 of 678 results

Page 8 of 28

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.